Migrafic 20mg Tablet SR
Marketer
Medon Pharmaceuticals Pvt Ltd
Salt Composition
Propranolol (20mg)
Overview Migrafic 20mg Tablet SR
Anxiolytic and tremor-reducing properties are offered by the extended-release Migrafic 20mg tablet. Its applications further encompass migraine prophylaxis, angina pectoris management, and the prevention of gastrointestinal hemorrhage secondary to portal hypertension. Additionally, Migrafic 20mg Tablet SR is indicated for hypertension and certain arrhythmias. Dosage is individualized based on the specific condition and patient response, always adhering to the physician's prescription. Optimal absorption requires administration on an empty stomach at consistent daily intervals. Continued use, even during symptom remission, is crucial to maintain therapeutic efficacy; abrupt cessation may exacerbate underlying conditions. Frequently reported adverse effects include fatigue, asthenia, Raynaud's phenomenon, bradycardia or arrhythmia, paresthesia, and dyspnea. Gastrointestinal disturbances such as nausea, emesis, and diarrhea may also occur. Persistent or bothersome side effects warrant medical consultation. The majority of side effects are transient and abate with continued therapy. Contraindications include asthma, severe bradycardia or arrhythmias, and significant cardiac compromise, including heart failure. Pre-existing renal or hepatic impairment, or COPD, necessitates physician consultation prior to initiation. Alcohol consumption should be avoided due to potential drug interactions. Operation of machinery, including driving, should be avoided if dizziness occurs. Consult your physician regarding the safety of Migrafic 20mg Tablet SR during pregnancy or lactation.
Uses of Migrafic 20mg Tablet SR
Managing angina (chest pain linked to heart disease), addressing arrhythmias, mitigating the risk of myocardial infarction, controlling hypertension (high blood pressure), alleviating anxiety, managing tremors, preventing migraine headaches, and treating pheochromocytoma.
Major Benefits of Migrafic 20mg Tablet SR:
Consume Migrafic 20mg Tablet SR precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. This medication should be taken on an empty stomach. Refrain from consuming Migrafic 20mg Tablet SR with meals high in fat, including those containing olive oil, nuts and seeds (like Brazil nuts), dark chocolate, butter, or meat.
Common Side effects of Migrafic 20mg Tablet SR:
- Cold extremities
- Sleep disturbance
- Fatigue
- Slow heart rate
- Nightmares
How to use Migrafic 20mg Tablet SR:
Administer Migrafic 20mg Tablet SR precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. This medication should be taken on an empty stomach. Refrain from consuming Migrafic 20mg Tablet SR concurrently with meals high in fat, including those containing olive oil, nuts and seeds (like Brazil nuts), dark chocolate, butter, or meat.
How Migrafic 20mg Tablet SR works:
Migrafic 20mg Extended-Release tablets utilize propranolol, a beta-adrenergic blocking agent. Its mechanism involves modulating the body's reaction to nerve signals, particularly within the cardiovascular system. This reduces heart rate and improves the heart's pumping efficiency, thus preventing irregular heartbeats. Simultaneously, it promotes vasodilation, enhancing circulation and mitigating both angina and migraine episodes. The precise mechanism for tremor reduction remains unclear, although it's hypothesized that Migrafic 20mg SR interferes with nerve impulses to the affected muscles. Furthermore, propranolol counteracts the effects of adrenaline and noradrenaline, neurotransmitters that elevate heart rate and contribute to anxiety; thus alleviating anxiety symptoms. In pheochromocytoma treatment, Migrafic 20mg SR inhibits excessive adrenaline-related hormones, mitigating the risk of dangerously elevated blood pressure during tumor resection.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Migrafic 20mg Tablet SR and alcohol is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Migrafic 20mg Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Migrafic 20mg tablets are likely unsuitable for breastfeeding mothers. Preliminary human studies indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
For individuals with severe kidney impairment, the use of Migrafic 20mg Extended-Release Tablets requires careful monitoring. Dosage modification of Migrafic 20mg Extended-Release Tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Migrafic 20mg sustained-release tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Migrafic 20mg Tablet SR :
Should you forget a Migrafic 20mg Tablet SR dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Migrafic 20mg Tablet SR
| Label | Value |
|---|---|
| Chemical Type | Naphthalene derivatives |
| Developing Habits | No. |
| Type of Therapy | HEART |
3,018 People bought this recently